Details, Fiction and cancer research
We’re creating a wide portfolio of research in notoriously challenging-to-handle cancers, and we can assist you as you progress into this industry.Article24 Apr 2024 One-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells in opposition to BCMA in relapsed many myeloma Merz and colleagues complete one-mobile m